Article
The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease
21 Feb 2017
Abstract excerpt
The use of the emerging "omics" technologies for large scale population screening is promising in terms of predictive, preventive and personalized medicine. For Parkinson's disease, it is essential that an accurate diagnosis is obtained and disease progression can be monitored. Immunoglobulin G (IgG) has the ability to exert both anti-inflammatory and pro-inflammatory effects, and the N-glycosylation of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
